Checking D-dimer in diabetic patients can often help to look for thrombosis and subsequently determine the presence of vasculopathy.
D-dimer is one of the coagulation tests. When the level of D-dimer is elevated, it indicates the existence of hypercoagulability in the body and secondary hyperfibrinolysis. Therefore, the concentration of D-dimer is clinically important for the diagnosis of thrombotic diseases, evaluation of the efficacy of treatment, and prognosis judgment.
Patients with diabetes mellitus who have poor long-term glycemic control are prone to develop large-vessel disease and subsequent thrombosis, so D-dimer screening in patients with diabetes mellitus is usually helpful in observing the presence or absence of thrombosis, which in turn helps to determine the presence or absence of vasculopathy.
Elevated D-dimer is commonly seen in patients with hypercoagulability, disseminated intravascular coagulation, and renal disease, or during thrombolysis. D-dimer is also elevated in patients with surgery, tumors, and infections, etc. Negative D-dimer can basically be used as a basis for clinical exclusion of pulmonary embolism.
Diabetic patients with D-dimer abnormalities are advised to seek medical attention.